Keytruda Market: Oncology Innovation & Forecast 2024

agregó una foto Networking

2026-07-14 17:16:07 -

Keytruda Market: Oncology Innovation & Forecast 2024–2034

Market Scope The Keytruda Market is witnessing significant growth as immunotherapy continues to transform modern cancer treatment. Keytruda (pembrolizumab), developed by Merck & Co., Inc., is one of the world's leading immune checkpoint inhibitors targeting the PD-1 pathway. It has become a preferred treatment option for a wide range of cancers, including non-small cell lung...

0 Commentarios 0 Acciones 319 Views 0 Vista previa